Cognetivity Neurosciences Ltd Investor Relations Material
Cognetivity Neurosciences Ltd. is a healthcare company, which engages in the development of an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia. The company was founded by Simone Ivonne Reinders and David Gill in 2017 and is headquartered in London, the United Kingdom
Latest company events
Ticker symbol
CGN
Country
About the company
Investor Relations Page
Dig deeper into the Cognetivity Neurosciences Ltd fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
